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Abstract
Serious concerns have been expressed about potential health risks of Nano silver containing 
consumer products (AgNPs) therefore regulatory health risk assessment on such nanoparticles 
has become mandatory for the safe use of AgNPsinbiomedicalproducts with special concerns 
to the mutagenic potentials. In this study, we examined the inhibitory and mutagenicity effects 
of AgNPs in three different sizes of three colloidal AgNPs by Minimal Inhibitory concentration 
(MIC), Minimal Bactericidal Concentration (MBC) and Bacterial Reverse Mutation Assay 
(Ames test).All samples were characterized by transmission electron microscopy (TEM), 
X-Ray Diffraction (XRD) and Dynamic Light Scattering (DLS). DLS analysis showed lack 
of large agglomeration of the AgNPs and TEM results showed the spherical AgNPswith the 
average sizes of 15, 19.6, 21.8 nms. Furthermore the XRD analysis showed the crystalline 
samples with a face centered cubic structure of pure silver.AmestestresultsonColloidal silver 
nanoparticles showed lack of any mutation in TA100, TA98, YG1029S. typhymuriumstrains.
In addition colloidal silver nanoparticles reduced the mutation ratesin all three strains in a 
concentration dependent manner .This finding creates a new issue in the possible antimutagenic 
effects of colloidal AgNPsas a new pharmaceutical productwhich should be consideredinfuture 
studiesby focusing onthephysicochemical properties of AgNPs.
Keywords: Mutagenicity;Nanosilver;AgNPs; Physicochemical Property;biomedical 
products.
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Introduction
For more than a century, Silver nanoparticles 
(AgNPs) were used as effective antiseptic 
agents,but in recent decade they have found 
increasing global concerns because of their 
strong antibacterial activities in comparison 
to silver and other antiseptic compounds(1). 
AgNPs containing products  comprising silver 
nanoparticles, are attracting interest for a range 
of biomedical and pharmaceutical applications 
owing to their potent antibacterial activities(2).
Moreover it has recently been demonstrated that 
AgNPhas useful anti-inflammatory effects which 
may accelerate  wound healing (1). The key to its 
broad-acting and potent antibacterial activity is 
the multifaceted mechanism by which AgNPacts 
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considered for their genotoxic potentials(8)
Out of different genotoxicity assessment 
methods, the Ames test is known as the most 
accurate and commonly used procedure to 
detect genotoxic carcinogens which cause two 
classes of gene mutation, base pair substitution 
and small frameshifts (9).Although this test is 
essential  within the current battery of assays 
required for genotoxicity evaluation and one 
of key assays recommended by the United 
Kingdom expert advisory Committee on 
Mutagen icity (7), its efficiency in genotoxicity 
assessment of various kinds of nanopar ticles 
has remained inconclusive.This studyaimed to 
compare themutagenic effects of a wide range of 
doses ofthree different commercially available 
colloidal AgNPsin similar sizes on the basis of 
their physicochemical properties especially by 
Ames Mutagenicity assay.
Experimental
Materials
AgNP commercial products
Three types of prevalent commercial 
products of colloidal silver nanoparticles 
were used for this study. The first commercial 
product of AgNPswas a yellowish-brown 
product, purchased from a local manufacturer in 
Tehran and coded as A-AgNP. According to the 
information provided by manufacturer, it was a 
water-based colloid which contained 4000 mg/
ml spherical uncoated  AgNP. The size and zeta 
on microbes. This is utilized in antibacterial 
coatings onmedicaldevices to reduce the rate 
of nosocomial infections. Many new synthesis 
methods have emerged and are being evaluated 
for AgNPproduction for medical applications (2).
This property has led the global and 
local markets  to many  new healthcare and 
cosmetic products, wound dressings, textiles, 
contraceptive devices, surgical instruments, 
bone prostheses, water purification systems, 
indoor air quality management and other 
products from AgNPs (3). Increased utilization 
of nanoparticles in recent years due to significant 
advances in nanotechnology havean impact 
on industrial technology with increased risk 
of human exposure to nanoparticles through 
occupational and environmental routs (4). 
The antibacterial properties of AgNPs are 
mainly attributed to their high surface area to 
volume ratio but this potential may cause their 
higher reactivity to macromolecules especially 
DNA reactions, their possible genotoxic effects, 
mutagen induced health risks propertiesand 
carcinogenic properties as well (5). According 
to the possible toxic potentials of AgNPs (6), 
many studies have revealed the association 
between  genotoxicity of AgNPs and their 
sizes. Although different size dependent 
genotoxiceffects from AgNP are reported by 
different methods in a dose-dependent manner 
(7), other physiochemical properties including 
zeta potential, shapes (rods, triangles, spherical 
particle) and aggregation capacities have been 
Figure 1. characterization of AgNPs by Transmission Electron Microscopy; A)Representative image of A-AgNP; B) Representative 
image of B-AgNP; C) Representative image of AgNPs water dispersion.
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potential of this sample was provided by TEM 
and DLS methodrespectively (Figure 1).
The second commercial AgNPs was donated 
by another local manufacturer in Isfahan and 
coded as B-AgNP. According to the information 
provided by manufacturer, it was water-based 
plant coated colloid contained 187.5 mg/ml of 
spherical silver nanoparticles. The size and zeta 
potential of this sample was provided by TEM 
and DLS method respectively(Figure 1).
The third colloidal silver nanoparticle was 
purchased from US Research nanomaterials co, 
Ltd (TX, USA).This product was a water based 
colloidal AgNPcontaining 1000 mg/ml spherical 
silver nanoparticles with 99.9% purity according 
to the information provided by the supplier. The 
size and zeta potential of this sample was provided 
by TEM and DLS methodrespectively (Figure 1).
Characterization of nanoparticles
The concentration of samples was determined 
by Atomic Absorption Spectroscopy (AAS). 
AgNPs were homogeneously dispersed in sterile 
distilled water by sonication for 30 minutes 
and filtered. Transmission electron microscopy 
(TEM) was used to estimate the size, shape and 
composition of the AgNPs. The distribution of 
the AgNPs, hydrodynamic size and zeta potential 
was evaluated using Dynamic light Scattering 
(model ZEN3600; Molvern instrument Ltd, 
Tokyo, Japan). The X-ray diffraction pattern was 
performed in order to characterize nanoparticle 
structure. Experimental methods were used to 
optimize the concentrations of each serial diluted 
samples and to assure the quality of provided 
data. All experiments were repeated at least three 
times to confirm the accuracy and reproducibility 
of this method. Standard gold nanoparticles with 
pre-determined size were used to validate the 
instrument. Both above parameters (size and 
zeta potential) were measured at least three times 
for each sample. The data were calculated as the 
average size or zeta potential of AgNPs.
Salmonella strains
The Salmonella Typhymurim strains used 
in this study were TA100, TA98 and YG1029 
a bacterial O-acetyltransferase-overproducing 
strain of TA100(10).The YG1029 was cloned and 
its activity was first described and established by 
T Nohmi and colleagues(11) who provided all 
strains as gift, from Biological Safety Research 
Center co, Ltd in Tokyo-Japan (2012).
MIC and MBC levels
The Minimal Inhibitory Concentration (MIC) 
value is the lowest concentration of AgNPs 
which prevents bacterial growths. Appropriate 
concentrations of each AgNPs samples 
were prepared according to their working 
manual,using muellerhintonbrothin the range of 
31.2-0.015 µg/ml with serial two fold dilutions 
of 1, 1/2, 1.4, 1/8, 1/16, 1/32, 1/64, 1/32, 1/64, 
1/128, 1/256, 1/512, 1/1024 inoculate 1×108 
colony forming units (CFU)/ml of tester strains. 
After 24h from incubation at 37ºC,MIC values 
for each strain were determined by choosing 
the lowest concentrations in which no growth 
occurs. Additionally, the minimal bactericidal 
concentration (MBC) values were determined by 
sub -culturing the content of each tube without 
any growth, on the Mueller Hinton agarmedium 
and looking for any bacterial growth(12). The 
MIC value was considered as the concentration 
with 99% bacterial growth inhibition and the 
MBC value was considered as the concentration 
with 100% of the inhibitory properties in 
comparison to the negative control.
Bacterial Reverse Mutation Assay
The pre-incubation Ames assay was 
performed according to the method of OECD 
471(13) .Before starting the main experiments, 
the mentioned strains were checked for their 
genetic integrity by histidine/biotin dependence, 
histidine dependence, biotin dependence, 
rfa marker(crystal violet) and the presence 
of plasmid pKM101 (Ampicillin resistance) 
tests (14; 15; 16).During all these preliminary 
experiments, the strains were grown overnight 
in nutrient brothfor 16-18h in incubator at 37ºC 
with a density of 1 - 2 × 108 (CFU) ml in presence 
of 25 µg/ml Ampicilin for TA98, TA100 and 10 
µg/ml Tetracycline for YG1029). The top agar 
was supplemented with histidine/biotin and 
prepared by dissolving 0.6g of agar-agarand 
0.6g NaCl in 100 ml distilled water. A sterilized 
aqueous solution of L-histidine and D-biotin 
(0.5 mM/L) was added to top agar medium 
immediately before applications(14; 16). In the 
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next step, 100 µl of overnight cultured bacteria 
with concentration of 1 - 2 × 108 CFU/ml were 
incubated at 37ºC for 45 min in a sterile glass tube 
containing 500 µlit sodium phosphate buffer (0.1 
M, pH7.4) with the different concentrations of the 
colloidal AgNPs. The concentration of AgNPs 
used in this study was 3.12-0.0015 µg/plate. 
After incubation, 2 ml of Top agar supplemented 
with histidine/biotin (kept in 45ºC water bath) 
and added to the mixture and mixed for 3 s using 
a vortex mixer, then poured on a plate of minimal 
glucose agar media(16). Plates were incubated 
for 48-72 h at 37ºC and the revertant colonies 
were counted. Three equal plates were used for 
each concentration and each experiment was 
repeated three times to get maximum accuracy 
and reproducibility for this sensitive method(17).
Data analysis
For the Ames mutagenicity assay, positive 
responses required a dose-related increase 
in the number of revertant colonies/plate for 
each of strains and sodium azide at5 µg/ml 
concentration (Sigma Aldrich, cat number: 
438456) was used as positive control. Negative 
response was defined as no concentration related 
increase in the number of revertant colonies and 
distilled water was used as negative control in 
this study. Also, a positive controlwas defined 
as an agent with defined concentration which 
can double the number of revertantcolonies/
plate in comparison to the vehicle control(17).
The Mutagenic Index (M.I) was described for 
each assay and calculated as the ratio between 
number of histidinerevertants induced per plate 
of the test sample and spontaneous revertants of 
the negative control(18).
Statistical analysis was performed using IBM 
SPSS statistics software version 20 and one-way 
ANOVA (LSD) was used to compare the colony 
counts of each plate in different concentrations 
and groups.Multifactorial analysis was carried 
out by considering the concentration as the 
main factor and p-values 0.05 was considered as 
statistically significant changes.
Results and Discussion
AgNPs characterization
As described above, three samples of 
commercial AgNPs were characterized by 
TEM, DLS and XRD methods (Table 1). 
The average particle sizeof aqueous colloidal 
silver nanoparticles A-AgNP, B-AgNP and 
C-AgNPwas19.6, 21.8 and 15 nm respectively. 
Shapes of AgNPs with 21.8 and 15 nm were 
spherical and different shapes were observed in 
AgNPs with 19.6 nm (Figure 1). All nanoparticle 
suspensions were stable and monodispersed with 
normal pH. The XRD showed crystalline pattern 
in all three samples .All samples had a face 
centered cubic structure of pure silver (Table 1)
MIC and MBC determination by broth serial 
macrodilution method
The inhibitory effects of different 
concentrations of AgNPs on three Salmonella 
strains were examined and described in Table 
2-4. Most of our experiments showed clearly 
that MIC and MBC levels were equal in all three 
samples. MIC and MBC of A-AgNP (19.6 nm) 
in TA100,TA98 and YG1029 were 3.9, 3.9, 7.81 
µg/ml respectively. MIC and MBC of B-AgNP 
(21.8 nm) in TA100,TA98 and YG1029 were 
also 3.9, 7.81, 15.6 µg/ml respectively. MIC and 
MBC of C-AgNP (15 nm) was equal to 3.9 µg/
ml in TA98 but in TA100 and YG1029 were 3.9, 
1.9 and 7.81, 3.9 µg/ml respectively.
Samples Concentration
1
(µg/ml) Shape
2 TEM 
size(nm2)
Hydrodynamic 
size(nm3)
Zeta potential 
mV(pH)2 Coting Style
Specific 
Gravity(cP) pH PDI
A-AgNP 4000 different 19.6 83.7 -12 uncoated 1.14 2.5 0.608
B-AgNP 187.5 spherical 21.8 52.56 -24.6 Plant coated 0.8872 4 0.516
C-AgNP 1000 spherical 15 62.4 -11.29 uncoated ND4 7 ND
Table 1. Physicochemical characteristics ofAgNPs.
1Determined by Atomic Absorption Spectroscopy (AAS)
2Determined by Transmission Electron Microscopy (TEM)
3Determined by Dynamic Light Scattering (DLS)
4Not determined
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upper than 0.78 µg/platewere considered toxic 
for TA100 and YG1029 (Table 2).
Out of 12 evaluated concentrations of 
A-AgNP, 8 concentrations (0.0015-0.0195 µg/
plate) showed lack of mutagenic potentials 
when compared with positive and negative 
controls.Significant lower colony numbers and 
MIs in above dilutions in comparison to the 
colony numbers in TA98 (95.6 ± 2.9), TA100 
(197 ± 2.08) and YG1029 (55.3 ± 2.6) showed 
inhibitory effects of Nanosilver with determined 
physicochemical properties  in these strains 
.Moreover YG1029 showed more sensitivity to 
higher concentrations of A-AgNP in this study 
(Table 2).
Mutagenic Potentials of B-AgNPs
Significant increase in the number of 
revertant colonies was detected in positive 
control plates when the number compared with 
negative control (< 0.001).The Mutagenicity 
Index (MI) was recorded as 9.2 ± 0.13for 
TA98, 4.5 ± 0.14 for TA 100 and 7.5 ± 0.19 
for YG1029.This observation indicated that 
Mutagenic potentials of AgNPs by Ames test
As described above, bacterial mutagenicity 
was assessed in S.typhimurium tester strain 
TA98 for detection of frameshift mutation, 
TA100 for measurement of base pair substitution 
and YG1029, that was derived from TA100, with 
the enzymatic activity of O-acetyltransferase 
for its point mutation capacities via metabolic 
activation. Details are described below:
Mutagenic Potentials of A-AgNPs
Significant increase in the number of revertant 
colonies was detected in positive control plates 
and the number compared with negative control (< 
0.001).The Mutagenicity Index (MI) was recorded 
as 9.75 ± 0.16 for TA98, 4.8 ± 0.009 for TA 100 and 
13.1 ± 0.35 for YG1029.This observation indicated 
that the test system is sensitive and specific to the 
mutagenic potentials of sodium azide in all three 
tester strains (Table 2).
The number of colonies and the MIs 
were calculated for 12 dilutions of A-AgNP 
.Concentrations upper than 0.39 µg/platewere 
considered toxic for TA98 and concentrations 
Mutagenic Index 
(SEM ± Mean)
Number of revertant colonies/Plate 
(SEM ± Mean)
Dose 
(µg/plate)
MIYG1029 MI TA100 MI TA98 YG1029 TA100 TA98
1.00 ± 0.00* 1.00 ± 0.00 1.00 ± 0.00 55.3 ± 2.6 197 ± 2.08 95.6 ± 2.9 0.00
0.68 ± 0.02* 0.86 ± 0.01* 0.79 ± 0.03* 37.3 ± 1.2 170 ± 1.2 ±1.769.6 0.0015
0.84 ± 0.03* 0.77 ± 0.006* 0.75 ± 0.02* 46.3 ± 1.4 153 ± 1.73 2.03  73.3± 0.003
0.87 ± 0.05* 0.79 ± 0.008* 0.58 ± 0.02*3 48.3 ± 0.88 156.3 ± 1.73 2.1   54.3± 0.006
0.9 ± 0.05* 0.82 ± 0.004* 1.00 ± 0.03 49.6 ± 0.66 162.3 ± 1.85 96.3 ± 2.02 0.012
0.64 ± 0.02* 0.83 ± 0.002* 0.85 ± 0.01* 35.6 ± 0.88 164.3 ± 1.3 79 ± 2.6 0.024
0.73 ± 0.01* 0.96 ± 0.0034 o.8 ± 0.01* 40.6 ± 1.2 190.3 ± 1.4 74.3 ± 2.02 0.048
0.76 ± 0.05* 0.87 ± 0.003 0.84 ± 0.08* 42.3 ± 0.88 172.6 ± 3.2 72.3 ± 1.6 0.097
0.84 ± 0.04* 0.89 ± 0.01 0.98 ± 0.03 46.6 ± 1.2 176.3 ± 1.6 91 ± 2.08 0.195
0.67 ± 0.04* ND ND 37 ± 1.1 T T 0.39
ND T 0.78
1.56
3.12
13.1 ± 0.35 4.8 ± 0.009 9.75 ± 0.16 726 ± 13.1 948 ± 10.7 926.6 ± 2.08 Positive control
1Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three 
times.
2Note: T denotes the toxic concentration of A-AgNP.Doses higherthan T could not be evaluated against; the positive control 
(sodiumazidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
3Highest inhibitory level was 0.58 ± 0.02.
*p <0.001, p < 0.05vs control.
Table 2. Mutagenicity ofA-AgNPs inS. Typhimurium tester strains (TA98, TA100, YG1029)1.
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the test system is sensitive and specific to the 
mutagenic potentials of sodium azide in all three 
tester strains (Table 3).The number of colonies 
and the MIs were calculated for 12 dilutions of 
A-AgNP.Concentrations upper than 0.39 µg/
plate were considered toxic for TA98 and TA100 
and concentrations upper than 1.56 µg/platewas 
considered toxic for YG1029 (Table 3).
Out of 12 evaluated concentrations of A- 
AgNP, 8 concentrations (0.0015-0.195 µg/
plate) showed lack of mutagenic potentials 
when compared with positive and negative 
controls .Significant lower colony numbers and 
MIs in above dilutions in comparison to the 
colony numbers in TA98 (100 ± 0.57), TA196.6 
(197 ± 8.81) and YG1029 (72 ± 1.4) showed 
inhibitory effects of Nanosilver with determined 
physicochemical properties in these strains 
.Moreover YG1029 showed more sensitivity to 
higher concentrations(0.39 and 0.78 µg/plate) of 
A-AgNP in this study (Table 3).
Mutagenicity Index 
(SEM±Mean)
Number of revertant colonies/ Plate 
(SEM±Mean)
Dose
(µg/plate)
MIYG1029 MI TA100 MI TA98 YG1029 TA100 TA98
1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 72 ± 1.4 196.6 ± 8.81 100 ± 0.57 0.00
 0.02 ± 0.76* 0.78 ± 0.03* 0.78 ± 0.03* 55.3 ± 1.2 153 ± 1.7 71.3 ± 1.45 0.0015
0.72 ± 0.01* 0.88 ± 0.04* 0.88 ± 0.04* 52.3 ± 1.2 173.3 ± 2.02 61.3 ± 1.45 0.003
0.68 ± 0.01* 0.73 ± 0.04* 0.73 ± 0.04* 50 ± 1.5 143.3 ± 2.02 64.3 ± 2.1 0.006
0.79 ± 0.06* 0.98 ± 0.03* 0.98 ± 0.03* 57 ± 1.2 192.3 ± 1.8 73 ± 1.15 0.012
0.86 ± 0.01* 0.82 ± 0.03* 0.82 ± 0.03* 62 ± 2.1 161.3 ± 0.8 82 ± 1.52 0.024
0.79 ± 0.02* 0.89 ± 0.03* 0.89 ± 0.03* 58 ± 2.6 175.3 ± 1.4 70.6 ± 1.2 0.048
0.65 ± 0.02* 0.97 ± 0.03* 0.97 ± 0.03* 48 ± 2.5 192 ± 1.5 84 ± 1.73 0.097
0.82 ± 0.02* 0.92 ± 0.04* 0.92 ± 0.04* 59 ± 2.9 180 ± 1.4 94.3 ± 2.4 0.195
0.84 ± 0.03* ND ND 61 ± 3.8 T T 0.39
0.85 ± 0.01* 62 ± 1.5 0.78
ND T 1.56
3.12
7.5 ± 0.19 4.5 ± 0.14 9.2 ± 0.13 580 ± 20.8 893 ± 12 926.6 ± 14.5 Positive control
Table 3. Mutagenicity of B-AgNP in S. Typhimurium tester strains (TA98, TA100.YG1029)1.
1Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three 
times.
2 Note: T denotes the toxic concentration of A-AgNP. Doses higher than T could not be evaluated against; the positive control (sodium 
azidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
*p <0.001, p < 0.05vs control.
Mutagenic Potentials of C-AgNPs
Significant increase in the number of revertant 
colonies was detected in positive control plates 
when the number compared with negative 
control (< 0.001).The Mutagenicity Index (MI) 
was recorded as 9.8 ± 0.28 for TA98, 4.8 ± 0.05 
for TA 100 and 8.3 ± 0.55 for YG1029.
This observation indicated that the test 
system is sensitive and specific to the mutagenic 
potentials of sodium azide in all three tester 
strains (Table 4).The number of colonies and 
the MIs were calculated for 12 dilutions of 
C-AgNP .Concentrations upper than 0.195 µg/
plate were considered toxic for TA98 and TA100 
and concentrations upper than 0.39 µg/plate was 
considered toxic for YG1029 (Table 4).
Out of 12 evaluated concentrations of A- 
AgNP, 8 concentrations (0.0015-0.195 µg/
plate) showed lack of mutagenic potentials when 
compared with positive and negative controls. 
Significant lower colony numbers and MIs in 
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above dilutions in comparison to the colony 
numbers in TA98 (197 ± 3.2), TA100 (190.3 ± 
2.6) and YG1029 (69.9 ± 2.4) showed inhibitory 
effects of Nanosilvercolloidal solution with 
determined physicochemical properties in 
these strains.Moreover YG1029 showed more 
sensitivity to a higher concentrations 0.39 µg/
plateof C-AgNP in this study (Table 4).
Our research focused on genotoxic effects of 
silvernanoparticles (AgNPs), which can be utilized 
in biomedical research, pharmaceutical products 
and environmental cleaning applications(19). 
Despite the widespread use of AgNPs in a wide 
range of biomedical products as a new group of 
health products,there are numerous knowledge 
gaps regarding their possible toxic potentials 
especially their mutagenic effects in human (8), 
(7). We described previously systemic toxic 
effects of AgNPs through dermal application 
in animal models (8),(1),(3) but limited studies 
on genotoxic effects ofAgNPs with dermal 
exposure has motivated us to continue our 
toxicity evaluations in this new area and this new 
bacterial settings for nanomaterials.
We defined three distinctive statistical groups 
Mutagenicity Index
(SEM ± Mean)
Number ofrevertant colonies/Plate
(SEM ± Mean)
MIYG1029 MI TA100 MI TA98 YG1029 TA100 TA98
1.00 ± 0.00 1.00 ± 0.00 1.00 ± 0.00 69.9 ± 2.4 190.3 ± 2.6 197 ± 3.2 0.00
0.64 ± 0.05* 0.9 ± 0.01* 0.52 ± 0.01* 45 ± 2.8 174.3 ± 2.3 95.6 ± 2.3 0.0015
0.75 ± 0.01* 0.8 ± 0.01* 0.66 ± 0.004* 52.6 ± 1.4 160 ± 0.5 50.6 ± 1.7 0.003
0.97 ± 0.02 0.7 ± 0.01* 0.85 ± 0.02* 67.6 ± 1.2 143.3 ± 0.3 63.6 ± 0.8 0.006
0.87 ± 0.03 0.7 ± 0.001* 0.78 ± 0.01* 61.3 ± 4.09 139.6 ± 2.02 81.3 ± 1.00 0.012
0.71 ± 0.06* 0.7 ± 0.007* 0.94 ± 0.01 49.3 ± 2.72 151.6 ± 0.6 75 ± 1.2 0.024
0.93 ± 0.017 0.8 ± 0.01* 0.87 ± 0.01* 65.3 ± 3.17 170 ± 0.57 90.6 ± 1.4 0.048
0.99 ± 0.06 0.7 ± 0.01* 0.97 ± 0.02 69.3 ± 2.02 135 ± 2.6 83.3 ± 1.00 0.097
0.85 ± 0.02 0.7 ± 0.01* 0.92 ± 0.04 59.3 ± 0.88 143 ± 1.7 93 ± 0.8 0.195
0.70 ± 0.05* ND ND 49 ± 2.3 T T 0.39
ND T 0.78
1.56
3.12
8.3 ± 0.55 4.8 ± 0.05 9.8 ± 0.28 580 ± 25.1 926.6 ± 20.8 943.3 ± 17.6 Positive control
1Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three 
times.
2 Note:T denotes the toxic concentration of A-AgNP. Doses higher than T could not be evaluated against; the positive control (sodium 
azidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
*p < 0.001, p < 0.05vs control.
Table 4. Mutagenicity of C-AgNPs in S.Typhimurium tester strains (TA98, TA100, YG1029)1.
as ‘‘A’’, ‘‘B’’, and ‘‘C’’ with 15-22 nm size 
and compared each one with negative control 
(Table 2-4) and positive control (Figure 2:2a, 
2b, 2c). The rational of this size selection was 
based on the results of one recent study which 
had introduced 20 nm AgNPsmuch more toxic 
than larger sizes due to their higher dissolution 
rate and larger surface area to volume ratio (20). 
Revertant colonies didn’t induced by the samples 
in a wide range of nontoxic concentrations but 
low AgNP concentrations showed significant 
inhibitory effects on TA98, TA100 and YG1024. 
In accordance to mentioned results, larger size 
AgNPs with 40-50 nm diameter (7) and lower 
sizes of AgNP with 5 nm diameter (17) could 
stop the growth of TA100 and TA98, in a dose-
dependent pattern but as a novel issue lower 
levels of revertant colonies even lower than the 
negative control responded properly. Although 
this preliminary finding suggests again the same 
result as before in a new range size, the clear 
and significant microbial inhibitory effects of all 
three samples (p < 0.001) suggest their possible 
antimutagenic effects of AgNPs with certain 
physicochemical properties which should be 
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2a: Mutagenicity of 19.6 nmAgNPs (A-AgNP)
2b: Mutagenicity of 21.8 nmAgNPs (B-AgNP).
2c: Mutagenicity of 15 nmAgNPs (B-AgNP).
Figure 2. Comparison of mutagenic effects of AgNPs with positive controlinS. typhimuriumtester strains (TA98, TA100. YG1029).
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considered for future experiments on certain 
mutagenic agents.
Other than the impact of size in mutagenic 
capacity,we considered the direct role of 
concentration and the indirect roles of shape, 
coating,zeta potential, PDI, pH and viscosity 
in this classic bioassay (16). The role of 
nanoparticle shapes e.g. rods, tatriangles and 
spherical particles(21) on bacterial toxicity has 
been described before in concentrations lower 
than MIC and MBC values (22).The shape of 
nanoparticles may modify the toxicity of AgNPs 
by changing the extents of Ag+ ions(22)but 
other than the role of shape,impact of coating 
was considered for gram negative bacterium 
pseudomonas putida and results showed no 
simple clear-cut relation between the toxicity 
of the different particles and their shapes and 
coatings.Actually the ion release kinetics could 
be considered as one the major factors for 
genotoxic effects of AgNPs, an issue which was 
not determined by us (23),(24).
Our result showed weak effects of 
physicochemical properties on mutagenicity 
potentials of AgNPS as well as no simple clear-
cut relation between coating and zeta potential 
of materials.There are several explanations 
for these negative ames results. Some studies 
showed that the negative results may be due 
to the inability of AgNPs to penetrate through 
the bacteria cell wall and lack of bacterial 
cells to perform endocytosis and incorporate 
them(7; 17; 15) but the underlying factor was 
the agglomeration of AgNPs which makes the 
particles too large to transport through the pores 
in bacterial cell wall. This lack of uptake could 
potentially lead to false negative results.
Colloidal silver nanoparticles did not 
induce mutations in TA100, TA98, YG1029 
S.typhymuriumstrains, so far they reduced the rate 
of mutaions in all three strains in a concentration 
dependent manner, a new issue which should 
be analyzed in next studies to assess their 
antimutagenic potentials. Moreover these data 
suggest the technical weakness of Ames test to 
evaluate the mutagenicity of the AgNPs.It seems 
that more genotoxic methods e.g. micronucleous 
assay, comet assay,chromosome aberration 
assay are necessary to assess the nanoparticle 
genotoxicity and their distinctive characteristics 
including size, shape, zeta potential, solubility, 
surface area.
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